Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Graff

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancers|February 25, 2023
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective AnalysisAmélie Aboudaram, Léonor Chaltiel, Damien Pouessel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 3, 2012
Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03Ivan Toledano, Pierre Graff, Antoine Serre, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2013
Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancerEric F Lartigau, Emmanuelle Tresch, Juliette Thariat, et al.
Journal of Radiation Research|February 4, 2012
Experimental model of naturally occurring post-radiation sarcoma: interest of positron emission tomography (PET) for early detectionBérengère Phulpin, Nguyen Tran, Agnès Leroux, et al.
Clinical and Translational Radiation Oncology|June 12, 2025
A GORTEC survey on low-risk CTV-P2 delineation in head and neck cancersMichel Lapeyre, Yoann Pointreau, Marc Alfonsi, et al.
Clinical and Translational Radiation Oncology|April 6, 2019
The GIRAFE phase II trial on MVCT-based "volumes of the day" and "dose of the day" addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancerVincent Esteyrie, Baptiste Gleyzolle, Amélie Lusque, et al.
Oral Oncology|July 10, 2017
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trialsYungan Tao, Anne Aupérin, Pierre Graff, et al.
The Lancet. Oncology|October 1, 2020
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trialPaul Sargos, Sylvie Chabaud, Igor Latorzeff, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2021
Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladderJonathan Khalifa, Stéphane Supiot, Géraldine Pignot, et al.
Critical Reviews in Oncology/Hematology|March 28, 2022
Highly hypofractionated schedules for localized prostate cancer: Recommendations of the GETUG radiation oncology groupAriane Lapierre, Christophe Hennequin, Amandine Beneux, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancers|February 25, 2023
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective AnalysisAmélie Aboudaram, Léonor Chaltiel, Damien Pouessel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 3, 2012
Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03Ivan Toledano, Pierre Graff, Antoine Serre, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2013
Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancerEric F Lartigau, Emmanuelle Tresch, Juliette Thariat, et al.
Journal of Radiation Research|February 4, 2012
Experimental model of naturally occurring post-radiation sarcoma: interest of positron emission tomography (PET) for early detectionBérengère Phulpin, Nguyen Tran, Agnès Leroux, et al.
Clinical and Translational Radiation Oncology|June 12, 2025
A GORTEC survey on low-risk CTV-P2 delineation in head and neck cancersMichel Lapeyre, Yoann Pointreau, Marc Alfonsi, et al.
Clinical and Translational Radiation Oncology|April 6, 2019
The GIRAFE phase II trial on MVCT-based "volumes of the day" and "dose of the day" addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancerVincent Esteyrie, Baptiste Gleyzolle, Amélie Lusque, et al.
Oral Oncology|July 10, 2017
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trialsYungan Tao, Anne Aupérin, Pierre Graff, et al.
The Lancet. Oncology|October 1, 2020
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trialPaul Sargos, Sylvie Chabaud, Igor Latorzeff, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2021
Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladderJonathan Khalifa, Stéphane Supiot, Géraldine Pignot, et al.
Critical Reviews in Oncology/Hematology|March 28, 2022
Highly hypofractionated schedules for localized prostate cancer: Recommendations of the GETUG radiation oncology groupAriane Lapierre, Christophe Hennequin, Amandine Beneux, et al.
Pageof 4